insulin and glp-1 agonist combination Clinical Focus on Agonists in Type 2 Diabetes Mellitus Evolution of GLP‐1 Receptor Agonists

The smaller final step from 8mg to 12mg (a 50% increase rather than a 100% doubling) reflects the finding that GI tolerability improves at higher doses once the body has already adapted to substantial receptor activation

[DOI] [PMC free article] [PubMed] [Google Scholar] 130.Raju M., Santhoshkumar P., Henzl T.M., Sharma K.K

M.VandoorneT.EckelmannB

Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms

Antidiabetic Effect of Abextide, a Long-Acting Exendin-4 Analogue in Cynomolgus Monkeys

"Plasma terminal half-life" (PDF)